Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Frei

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Antiviral Therapy|February 4, 2012
The vitamin D receptor gene bAt (CCA) haplotype impairs the response to pegylated-interferon/ribavirin-based therapy in chronic hepatitis C patientsKatharina Baur, Joachim C Mertens, Johannes Schmitt, et al.
Journal of Crohn'S & Colitis|June 9, 2014
The effectiveness and safety of rescue treatments in 108 patients with steroid-refractory ulcerative colitis with sequential rescue therapies in a subgroup of patientsMarijana Protic, Frank Seibold, Alain Schoepfer, et al.
Plos One|April 26, 2019
Association of IBD specific treatment and prevalence of pain in the Swiss IBD cohort studyLorenz Bon, Sylvie Scharl, Stephan Vavricka, et al.
Journal of Crohn'S & Colitis|June 28, 2015
High Rates of Smoking Especially in Female Crohn's Disease Patients and Low Use of Supportive Measures to Achieve Smoking Cessation--Data from the Swiss IBD Cohort StudyLuc Biedermann, Nicolas Fournier, Benjamin Misselwitz, et al.
Journal of Crohn'S & Colitis|August 20, 2013
High altitude journeys and flights are associated with an increased risk of flares in inflammatory bowel disease patientsStephan R Vavricka, Gerhard Rogler, Sandra Maetzler, et al.
Plos One|October 13, 2017
Risk factors for gallstones and kidney stones in a cohort of patients with inflammatory bowel diseasesStefania Fagagnini, Henriette Heinrich, Jean-Benoît Rossel, et al.
Digestion|March 2, 2016
The Clinical Relevance of the IBD-Associated Variation within the Risk Gene Locus Encoding Protein Tyrosine Phosphatase Non-Receptor Type 2 in Patients of the Swiss IBD CohortMarianne R Spalinger, Marius Voegelin, Luc Biedermann, et al.
Inflammatory Bowel Diseases|November 13, 2013
Periodontitis and gingivitis in inflammatory bowel disease: a case-control studyStephan R Vavricka, Christine N Manser, Sebastian Hediger, et al.
Journal of Crohn'S & Colitis|August 14, 2012
Bilberry ingestion improves disease activity in mild to moderate ulcerative colitis - an open pilot studyLuc Biedermann, Jessica Mwinyi, Michael Scharl, et al.
Digestive Diseases (Basel, Switzerland)|June 9, 2017
Long-Term Efficacy and Safety of Certolizumab Pegol in an Unselected Crohn's Disease Population: The FACTS III SurveyStephan R Vavricka, Milos Spasojevic, Gerhard Rogler, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Antiviral Therapy|February 4, 2012
The vitamin D receptor gene bAt (CCA) haplotype impairs the response to pegylated-interferon/ribavirin-based therapy in chronic hepatitis C patientsKatharina Baur, Joachim C Mertens, Johannes Schmitt, et al.
Journal of Crohn'S & Colitis|June 9, 2014
The effectiveness and safety of rescue treatments in 108 patients with steroid-refractory ulcerative colitis with sequential rescue therapies in a subgroup of patientsMarijana Protic, Frank Seibold, Alain Schoepfer, et al.
Plos One|April 26, 2019
Association of IBD specific treatment and prevalence of pain in the Swiss IBD cohort studyLorenz Bon, Sylvie Scharl, Stephan Vavricka, et al.
Journal of Crohn'S & Colitis|June 28, 2015
High Rates of Smoking Especially in Female Crohn's Disease Patients and Low Use of Supportive Measures to Achieve Smoking Cessation--Data from the Swiss IBD Cohort StudyLuc Biedermann, Nicolas Fournier, Benjamin Misselwitz, et al.
Journal of Crohn'S & Colitis|August 20, 2013
High altitude journeys and flights are associated with an increased risk of flares in inflammatory bowel disease patientsStephan R Vavricka, Gerhard Rogler, Sandra Maetzler, et al.
Plos One|October 13, 2017
Risk factors for gallstones and kidney stones in a cohort of patients with inflammatory bowel diseasesStefania Fagagnini, Henriette Heinrich, Jean-Benoît Rossel, et al.
Digestion|March 2, 2016
The Clinical Relevance of the IBD-Associated Variation within the Risk Gene Locus Encoding Protein Tyrosine Phosphatase Non-Receptor Type 2 in Patients of the Swiss IBD CohortMarianne R Spalinger, Marius Voegelin, Luc Biedermann, et al.
Inflammatory Bowel Diseases|November 13, 2013
Periodontitis and gingivitis in inflammatory bowel disease: a case-control studyStephan R Vavricka, Christine N Manser, Sebastian Hediger, et al.
Journal of Crohn'S & Colitis|August 14, 2012
Bilberry ingestion improves disease activity in mild to moderate ulcerative colitis - an open pilot studyLuc Biedermann, Jessica Mwinyi, Michael Scharl, et al.
Digestive Diseases (Basel, Switzerland)|June 9, 2017
Long-Term Efficacy and Safety of Certolizumab Pegol in an Unselected Crohn's Disease Population: The FACTS III SurveyStephan R Vavricka, Milos Spasojevic, Gerhard Rogler, et al.
Pageof 6